Stella Pharma Corp Ordinary Shares 4888
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- JPY 298.00
- Day Range
- JPY 298.00–303.00
- 52-Week Range
- JPY 229.00–363.00
- Bid/Ask
- JPY 298.00 / JPY 300.00
- Market Cap
- JPY 9.37 Bil
- Volume/Avg
- 14,900 / 171,698
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 35.83
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Stella Pharma Corp is a therapeutic drug research and development company. It is focused on the development of boron compounds, particularly used in boron neutron capture therapy (BNCT). The BNCT is a form of cancer radiation therapy for destroying cancer cells.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Growth
- Total Number of Employees
- 49
- Website
- https://stella-pharma.co.jp
Comparables
Valuation
|
Metric
|
4888
|
4893
|
4563
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | — |
Price/Book Value | 3.48 | 1.20 | 0.37 |
Price/Sales | 35.83 | 20.68 | 60.63 |
Price/Cash Flow | — | — | — |
Price/Earnings
4888
4893
4563
Financial Strength
|
Metric
|
4888
|
4893
|
4563
|
|---|---|---|---|
Quick Ratio | 11.55 | 65.18 | 1.68 |
Current Ratio | 16.50 | 66.28 | 2.38 |
Interest Coverage | −353.19 | — | — |
Quick Ratio
4888
4893
4563
Profitability
|
Metric
|
4888
|
4893
|
4563
|
|---|---|---|---|
Return on Assets (Normalized) | −18.46% | −19.85% | −16.00% |
Return on Equity (Normalized) | −27.79% | −20.61% | −19.90% |
Return on Invested Capital (Normalized) | −20.06% | −20.61% | −19.26% |
Return on Assets
4888
4893
4563
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Zgdnrdsrhh | Xmltr | $578.5 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Vwdbdxpb | Bxvdzmr | $101.5 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Ktxfjqq | Jjbyngf | $99.5 Bil | |
MRNA
| Moderna Inc | Fllbkkvn | Bchp | $42.7 Bil | |
ARGX
| argenx SE ADR | Bjhmjwpj | Htsgm | $22.2 Bil | |
BNTX
| BioNTech SE ADR | Tvnwhkwfz | Mmpkg | $21.4 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Tcccrpmw | Vgbzhv | $18.2 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Vqrkflkl | Rhggdwz | $15.3 Bil | |
RPRX
| Royalty Pharma PLC Class A | Vnmgthsftf | Fhffqn | $12.7 Bil | |
INCY
| Incyte Corp | Xxrtygxdd | Zhghmb | $11.9 Bil |